Background Colorectal cancer (CRC) is one of the leading cause of cancer deaths
worldwide. Since CRC is largely asymptomatic until alarm features develop to advanced …

Colorectal cancer (CRC) is one of the most common cancer worldwide and results from the
accumulation of mutations and epimutations in colonic mucosa cells ultimately leading to …

Perineural invasion (PNI) is a possible route for metastatic spread in various cancer types,
including colorectal cancer (CRC). PNI is linked to poor prognosis, but systematic analyses …

RNA interference (RNAi) offers the potential to treat disease at the earliest onset by
selectively turning off the expression of target genes, such as intracellular oncogenes that …

In spite of the current advances and achievements in cancer treatments, colorectal cancer
(CRC) persists as one of the most prevalent and deadly tumor types in both men and women …

To date, anticancer immunotherapy has presented some clinical benefits to most of
advanced mismatch repair deficient (dMMR)/microsatellite instability‐high (MSI‐H) …

Abstract Wingless-type protein (Wnt)/β-catenin pathway alterations in non-small cell lung
cancer (NSCLC) are associated with poor prognosis and resistance. In 598 stage III–IV …

Canonical Wnt signaling is a highly conserved pathway with a prominent role in
embryogenic development, adult tissue homeostasis, cell polarization, stem cell biology, cell …

Colorectal cancer (CRC) is the third leading cause of cancer‑associated mortality worldwide.
Ginsenoside Rh1 (Rh1) is a traditional medicine monomer with antitumor activity; however …

Sun T, Liu Z, Zhang R, et al. Onco Targets Ther. 2020; 13: 2957-2972. We, the Editors and
Publisher of OncoTargets and Therapy, have retracted the following article. Concerns were …